Attention Deficit Disorder, Substance Use Disorder, Impulsivity, personality disorders ADHD, substance use, impulsivity, personality disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria for participation in the treatment program are: men between the age of 18 – 65 years, ADHD (all subtypes) as classified in the DSM-5, SUD according to DSM-5, being in outpatient treatment, and written informed consent. As we chose an observational design from a real-life setting, there are no additional study inclusion criteria. We expect to have sufficient number of patients (N=32) for our analyses after finalization of four consecutive groups at the psychiatry department of the Radboud University Medical Center. Patient data will be collected from routine outcome measurements between 2023 and 2027.
Exclusion criteria
Exclusion criteria: Exclusion criteria for participation in the treatment program are the inability to participate due to cognitive impairments, psychotic symptoms and/or insufficient understanding of the Dutch language (clinical judgment). Patients that do not provide consent for the use of their clinical data will be allowed to participate in the program, but their data will be excluded from any scientific analyses.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study parameter during this 9-month ‘group-based DST’ program is the improvement of patients’ ADHD symptoms (measured with the ASRS) and substance use or craving (measured with the MATE and diary cards). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary parameters in this treatment program aimed to improve emotion regulation skills and hereby reduce (mal)adaptive schemas and modes (measured with the YSQ, SMI and diary cards) and improve functional outcomes (measured with the WHODAS). | — |
Countries
Netherlands
Contacts
Radboud Universitair Medisch Centrum